VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NODK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NODKNI Holdings, Inc.
$15.77$323M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNODKQuarterly Financials

NI Holdings, Inc. (NODK) Quarterly Financials

120+ quarters historyFree accessUpdated daily

NI Holdings, Inc. (NODK) quarterly income statement — complete revenue, gross profit & net income history

NODK Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue59.6M60.99M76.57M76.06M71.43M73.91M88.98M87.81M74.5M94.41M78.03M81.08M81.56M93.33M89.17M75.79M66.14M85.35M84.61M83.21M
Revenue Growth %-16.56%-17.48%-13.95%-13.38%-4.11%-21.71%14.04%8.3%-8.65%1.16%-12.5%6.97%23.31%9.35%5.4%-8.92%-6.58%2.04%4.64%-13.02%
Medical Costs & Claims23.36M52.83M69.92M82.98M55.05M50.4M82.72M88.65M56.96M67.98M69.68M76.86M77.41M84.14M96.51M124.84M55.75M51.36M78.64M82.8M
Medical Cost Ratio %39.19%86.61%91.32%109.1%77.07%68.18%92.96%100.96%76.46%72%89.3%94.8%94.92%90.15%108.22%164.72%84.29%60.17%92.95%99.51%
Gross Profit36.25M8.17M6.65M-6.92M16.38M23.52M6.27M-841K17.54M26.43M8.35M4.21M4.14M9.19M-7.33M-49.05M10.39M34M5.97M408K
Gross Margin %60.81%13.39%8.68%-9.1%22.93%31.82%7.04%-0.96%23.54%28%10.7%5.2%5.08%9.85%-8.22%-64.72%15.71%39.83%7.05%0.49%
Gross Profit Growth %121.27%-65.28%6.03%-723.31%-6.6%-11.04%-24.93%-119.96%323.32%187.52%213.89%108.59%-60.12%-72.96%-222.82%-12121.81%-71.55%-34.47%-77.64%-99.16%
Operating Expenses20.54M11.06M8.5M8.4M8.63M9.68M9.72M8.23M8.71M14.91M7.33M7.47M9.66M8.54M5.91M10M7.78M25.59M12.45M3.7M
OpEx / Revenue %34.46%18.14%11.11%11.04%12.08%13.09%10.93%9.37%11.68%15.79%9.39%9.22%11.84%9.15%6.63%13.2%11.76%29.98%14.71%4.45%
Depreciation & Amortization168K275K175K171K173K154K186K187K154K374K164K34K300K309K291K294K286K309K280K289K
Combined Ratio %73.64%104.75%102.43%120.15%89.15%81.28%103.88%110.33%88.14%87.79%98.69%104.02%106.76%99.29%114.85%177.91%96.06%90.15%107.66%103.96%
Operating Income15.71M-2.9M-1.86M-15.32M7.75M13.84M-3.46M-9.07M8.83M11.53M1.02M-3.26M-5.51M658K-13.24M-59.05M2.61M8.41M-6.48M-3.29M
Operating Margin %26.36%-4.75%-2.43%-20.15%10.85%18.72%-3.88%-10.33%11.86%12.21%1.31%-4.02%-6.76%0.71%-14.85%-77.91%3.94%9.85%-7.66%-3.96%
Operating Income Growth %102.74%-120.93%46.24%-68.95%-12.27%20.06%-439.16%-178.14%260.22%1651.67%107.69%94.48%-311.47%-92.18%-104.34%-1692.14%-79.43%-70.65%-232.97%-113.92%
EBITDA15.88M-2.62M-1.68M-15.15M7.92M13.99M-3.27M-8.88M8.99M11.9M1.18M-3.23M-5.21M967K-12.95M-58.76M2.89M8.72M-6.2M-3.01M
EBITDA Margin %26.64%-4.3%-2.2%-19.92%11.09%18.93%-3.67%-10.12%12.06%12.6%1.52%-3.98%-6.39%1.04%-14.52%-77.53%4.37%10.22%-7.33%-3.61%
Interest Expense00000000000000000000
Non-Operating Income00000000000000000000
Pretax Income15.71M-2.9M-1.86M-15.32M7.75M13.84M-3.46M-9.07M8.83M11.53M1.02M-3.26M-5.51M658K-13.24M-59.05M2.61M8.41M-6.48M-3.29M
Pretax Margin %26.36%-4.75%-2.43%-20.15%10.85%18.72%-3.88%-10.33%11.86%12.21%1.31%-4.02%-6.76%0.71%-14.85%-77.91%3.94%9.85%-7.66%-3.96%
Income Tax3.2M260K-192K-3.27M1.29M3.99M-751K-1.59M1.9M4.32M214K-685K-1.01M-333K-3.07M-12.41M568K2.27M-1.62M-561K
Effective Tax Rate %20.38%-8.98%10.33%21.36%16.63%28.83%21.73%17.55%21.49%37.44%21%21.01%18.37%-50.61%23.21%21.02%21.79%26.96%25.03%17.03%
Net Income12.51M-3.16M-1.67M-12.05M6.46M9.85M-2.71M-19.62M6.42M6.63M231K-8.12M-4.21M890K-9.98M-45.91M1.91M6.13M-4.74M-2.64M
Net Margin %20.99%-5.17%-2.18%-15.84%9.04%13.32%-3.04%-22.35%8.62%7.02%0.3%-10.02%-5.16%0.95%-11.2%-60.58%2.89%7.18%-5.6%-3.18%
Net Income Growth %93.62%-132.05%38.41%38.58%0.64%48.65%-1271%-141.59%252.47%644.38%102.31%82.31%-320.53%-85.48%-110.79%-1636.38%-80.26%-71.6%-229.28%-114.11%
EPS (Diluted)0.60-0.15-0.08-0.570.310.47-0.13-0.400.310.310.01-0.38-0.200.04-0.47-2.150.090.29-0.22-0.12
EPS Growth %93.55%-131.91%38.46%-42.5%0%51.61%-1292.66%-5.26%255%634.6%102.32%82.33%-326.5%-85.45%-113.64%-1691.67%-80.38%-71%-229.41%-114.12%
EPS (Basic)0.60-0.15-0.08-0.570.310.48-0.13-0.360.310.320.01-0.38-0.200.04-0.47-2.150.090.29-0.22-0.12
Diluted Shares Outstanding20.94M20.55M21M21.04M21.1M21.04M20.98M20.97M21.05M21.33M21.19M21.28M21.37M21.08M21.33M21.38M21.61M21.41M21.41M21.46M